Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pignolo, Robert J
ANDECAL, NCT06508021: A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)	Recruiting	2/3	92	US	Andecaliximab, Placebo	Ashibio Inc	Fibrodysplasia Ossificans Progressiva	02/29	02/29
AFFIRM, NCT03430037: Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women	Enrolling by invitation	2	40	US	Fisetin, Placebo oral capsule, Placebo	Mayo Clinic	Frail Elderly Syndrome	10/25	10/25
AFFIRM-LITE, NCT03675724: Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults	Enrolling by invitation	2	40	US	Fisetin, Placebo oral capsule	Mayo Clinic	Frail Elderly Syndrome	10/25	10/25
Kaplan, Frederick S
No trials found